Inspire Medical Systems, Inc. vs Merck & Company, Inc. — Stock Comparison
Inspire Medical Systems, Inc. (INSP) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Inspire Medical Systems, Inc. and Merck & Company, Inc. are evenly matched on Q·Score (7/10 each). Merck & Company, Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for INSP (+22.4%) than for MRK (+13.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
INSP vs MRK: which stock scores better overall?
Based on Q·Score, Inspire Medical Systems, Inc. (INSP) scores 7/10 versus Merck & Company, Inc. (MRK) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: INSP or MRK?
Inspire Medical Systems, Inc. (INSP) scores higher on Growth (6.2/10 vs 6.2/10). Inspire Medical Systems, Inc. reports revenue growth (1.6% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is INSP or MRK more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (6.7/10 vs 6/10). INSP trades at 32.6× P/E versus MRK at 11.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about INSP vs MRK?
There are 12 analysts covering INSP with a consensus price target of $52.17, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: INSP or MRK?
Inspire Medical Systems, Inc. (INSP) scores higher on Quality (8/10 vs 7.7/10). Net profit margin: INSP at 14.3%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: INSP or MRK?
Inspire Medical Systems, Inc. (INSP) scores higher on Financial Health (9.7/10 vs 7/10). Market beta: INSP at 0.73, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of INSP and MRK?
Inspire Medical Systems, Inc. (INSP) has a market capitalisation of $1.2B, while Merck & Company, Inc. (MRK) has a market cap of $281.2B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do INSP or MRK pay dividends?
INSP does not currently pay a dividend, while MRK pays a dividend yield of 2.95%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →